Many countries oppose the United States' import drug tariff policy.

On the 25th, President Trump of the United States announced that starting from October 1st, the United States will impose a 100% tariff on all imported branded or patented drugs. On the 26th, Australian Minister of Health and Aged Care Mark Butler told the media that the new tariff policy announced by the US government not only lacks basis, but also poses a challenge to the economic and trade cooperation between the two countries, which is "unfair and unreasonable" for Australia. On the same day, the Belgian Pharmaceutical Association issued a statement stating that Trump's latest tariff policy violates the trade agreement previously reached between the European Union and the United States, and may have a significant impact on the Belgian pharmaceutical industry. The Association of Research-based Pharmaceutical Companies in Germany also stated on the 26th that if the United States implements the new tariff policy, it will severely hurt the German and European pharmaceutical industries.